We have located links that may give you full text access.
Presenting symptoms of pediatric brain tumors diagnosed in the emergency department.
Pediatric Emergency Care 2014 Februrary
OBJECTIVE: The primary objective of this study is to categorize the symptoms associated with brain tumors as diagnosed in the emergency department (ED). The secondary objective is to detail the specific characteristics of these headaches via a subgroup analysis.
METHODS: A retrospective chart review was performed among patients younger than 18 years presenting to a large urban tertiary care facility. Electronic medical records were searched and reviewed from 2002 to 2011 for inpatient discharge diagnoses using malignant and benign central nervous system tumor International Classification of Diseases, Ninth Revision codes.
RESULTS: The electronic records of ED visits for 87 patients were reviewed. The most frequent signs and symptoms were as follows: headache (66.7%), hydrocephalus (58.6%), nausea/vomiting (49.4%), gait disturbance (42.5%), vision changes (20.7%), seizure (17.2%), behavior/school change (17.2%), cranial nerve deficits (16.1%), altered mental status (16.1%), back/neck pain (16.1%), papilledema (12.6%), facial asymmetry (10.3%), sensory deficits (8.0%), focal motor weakness (6.9%), cranial nerve 6 deficit (6.9%), ptosis (5.7%), macrocephaly (4.6%), asymptomatic (3.4%), and anisocoria (1.1%). The frequencies of location of headache were diffuse (24.1%), frontal (12.1%), occipital (8.6%), and parietal/temporal (6.9%). The severity was described as severe (37.9%) followed by moderate and mild (10.3% and 5.2%, respectively). Most headaches occurred in the morning (13.8%) and night (12.1%), and their quality was predominantly progressively worsening (50.0%)
CONCLUSIONS: Brain tumors diagnosed in the ED most commonly present with headache, hydrocephalus, nausea/vomiting, and gate disturbances. The headaches are described as progressively worsening and diffuse most commonly occurring in the morning and night.
METHODS: A retrospective chart review was performed among patients younger than 18 years presenting to a large urban tertiary care facility. Electronic medical records were searched and reviewed from 2002 to 2011 for inpatient discharge diagnoses using malignant and benign central nervous system tumor International Classification of Diseases, Ninth Revision codes.
RESULTS: The electronic records of ED visits for 87 patients were reviewed. The most frequent signs and symptoms were as follows: headache (66.7%), hydrocephalus (58.6%), nausea/vomiting (49.4%), gait disturbance (42.5%), vision changes (20.7%), seizure (17.2%), behavior/school change (17.2%), cranial nerve deficits (16.1%), altered mental status (16.1%), back/neck pain (16.1%), papilledema (12.6%), facial asymmetry (10.3%), sensory deficits (8.0%), focal motor weakness (6.9%), cranial nerve 6 deficit (6.9%), ptosis (5.7%), macrocephaly (4.6%), asymptomatic (3.4%), and anisocoria (1.1%). The frequencies of location of headache were diffuse (24.1%), frontal (12.1%), occipital (8.6%), and parietal/temporal (6.9%). The severity was described as severe (37.9%) followed by moderate and mild (10.3% and 5.2%, respectively). Most headaches occurred in the morning (13.8%) and night (12.1%), and their quality was predominantly progressively worsening (50.0%)
CONCLUSIONS: Brain tumors diagnosed in the ED most commonly present with headache, hydrocephalus, nausea/vomiting, and gate disturbances. The headaches are described as progressively worsening and diffuse most commonly occurring in the morning and night.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app